What is the difference between ipamorelin and sermorelin?

They act on different receptors. Ipamorelin is a selective ghrelin/GHS-receptor secretagogue (GHRP class) that mimics ghrelin signalling; sermorelin is a GHRH (1-29) analogue acting on the GHRH receptor. They engage the growth-hormone axis from two different entry points and are not interchangeable in research design.

Why is ipamorelin paired with CJC-1295 and not sermorelin?

Pairing a ghrelin-receptor secretagogue (ipamorelin) with a GHRH-pathway agonist engages two complementary mechanisms. CJC-1295 is the GHRH-side partner because it is an engineered, longer-acting GHRH analogue, whereas sermorelin (GHRH 1-29) is short-lived in solution. Pairing ipamorelin with sermorelin would not add the same complementary stability.

Does Titan sell sermorelin?

Titan stocks the CJC-1295 + ipamorelin blend ($119.99), not standalone sermorelin. For studying the GHS-R secretagogue side of GH signalling alongside an engineered GHRH analogue, the blend is the in-stock tool, supplied with a lot-matched release sheet and HPLC purity target.

Is CJC-1295 better than sermorelin?

They are not directly competing — both are GHRH-pathway compounds, but CJC-1295 was engineered for a longer duration of action than sermorelin (GHRH 1-29), which is why it appears in most modern research blends. The cjc-1295-vs-ipamorelin page covers the GHRH-vs-GHS distinction in detail.

Are these compounds approved for human use?

No. Research-grade ipamorelin, CJC-1295, and sermorelin sold as reagents are not approved for human use. Titan supplies its blend strictly as a research-use-only compound for in-vitro laboratory work — not for human or animal consumption, and not for diagnostic, therapeutic, or preventative use.

Ipamorelin vs sermorelin · research comparison

Ipamorelin vs sermorelin: two different ways to study GH signalling.

Ipamorelin and sermorelin both appear in growth-hormone research, but they act on different receptors and are not interchangeable. Ipamorelin is a selective ghrelin-receptor (GHS-R) secretagogue; sermorelin is a GHRH analogue acting on the GHRH receptor. This page compares the two as research compounds and explains why ipamorelin is most often studied alongside CJC-1295 rather than sermorelin.

CJC-1295 + Ipamorelin — $119.99 CJC-1295 vs Ipamorelin

Two different receptors

Ipamorelin is a selective growth-hormone secretagogue acting on the ghrelin/GHS receptor — it mimics ghrelin's signalling without the appetite or cortisol/prolactin effects of older GHRPs. Sermorelin is a GHRH (1-29) analogue acting on the GHRH receptor — it mimics the upstream hypothalamic releasing hormone. They engage the GH axis from two different entry points.

CJC-1295 + Ipamorelin guide →

Why ipamorelin is paired with CJC-1295

In the research literature ipamorelin (a GHS-R secretagogue) is most often paired with CJC-1295 (a GHRH analogue) rather than with sermorelin — because pairing a ghrelin-receptor agonist with a GHRH-pathway agonist engages two complementary mechanisms at once. Sermorelin and CJC-1295 are both GHRH-pathway compounds, so they overlap rather than complement.

CJC-1295 vs Ipamorelin →

Stability and format

Sermorelin (GHRH 1-29) is comparatively short-lived in solution. CJC-1295 was engineered as a longer-acting GHRH analogue, which is why it — not sermorelin — is the GHRH-side partner in most modern research blends. Titan stocks the CJC-1295 + ipamorelin blend as a single 5mg/5mg lyophilized vial for reconstitution before in-vitro use.

COA red flags for the blend →

What Titan stocks

Titan stocks the CJC-1295 + ipamorelin blend ($119.99), not standalone sermorelin. For studying the GHS-R secretagogue side of GH signalling, ipamorelin is the in-stock tool — paired with the engineered GHRH analogue. Each lot ships with a lot-matched release sheet, HPLC purity target, and mass-spec identity confirmation.

Where to buy the blend →

How to source it

Titan is crypto-only — BTC, USDC, or SOL. The network and wallet are shown before payment and an order ID is logged with support first. Paying in USDC holds the total at the quoted figure. FIRST10/BULK15/TITAN20/VIP25 codes apply at checkout.

Crypto checkout walkthrough →

Where the research-use line sits

Both ipamorelin and sermorelin are research reagents in this context. Nothing here is dosing guidance or a human-use protocol — it describes how the two are positioned in published GH-axis research and how to source documented material. Neither is supplied for human use.

See the testing workflow →

The detail, in plain terms

GHS-R secretagogue vs GHRH analogue.

Ipamorelin and sermorelin both touch the growth-hormone axis, but through different receptors — which is exactly why ipamorelin's standard research partner is the engineered GHRH analogue CJC-1295, not sermorelin.

Ipamorelin: Selective ghrelin/GHS-receptor secretagogue — GHRP class.
Sermorelin: GHRH (1-29) analogue — acts on the GHRH receptor, short-lived in solution.
Standard pairing: Ipamorelin + CJC-1295 (GHRH analogue) — two complementary mechanisms.
Why not sermorelin: Sermorelin and CJC-1295 are both GHRH-side — they overlap, not complement.
Titan stocks: CJC-1295 + ipamorelin blend, 5mg/5mg lyophilized, $119.99.
Checkout: Crypto-only — BTC, USDC, SOL; on-chain confirm before dispatch.

Questions researchers ask

Before you order.

What is the difference between ipamorelin and sermorelin?: They act on different receptors. Ipamorelin is a selective ghrelin/GHS-receptor secretagogue (GHRP class) that mimics ghrelin signalling; sermorelin is a GHRH (1-29) analogue acting on the GHRH receptor. They engage the growth-hormone axis from two different entry points and are not interchangeable in research design.
Why is ipamorelin paired with CJC-1295 and not sermorelin?: Pairing a ghrelin-receptor secretagogue (ipamorelin) with a GHRH-pathway agonist engages two complementary mechanisms. CJC-1295 is the GHRH-side partner because it is an engineered, longer-acting GHRH analogue, whereas sermorelin (GHRH 1-29) is short-lived in solution. Pairing ipamorelin with sermorelin would not add the same complementary stability.
Does Titan sell sermorelin?: Titan stocks the CJC-1295 + ipamorelin blend ($119.99), not standalone sermorelin. For studying the GHS-R secretagogue side of GH signalling alongside an engineered GHRH analogue, the blend is the in-stock tool, supplied with a lot-matched release sheet and HPLC purity target.
Is CJC-1295 better than sermorelin?: They are not directly competing — both are GHRH-pathway compounds, but CJC-1295 was engineered for a longer duration of action than sermorelin (GHRH 1-29), which is why it appears in most modern research blends. The cjc-1295-vs-ipamorelin page covers the GHRH-vs-GHS distinction in detail.
Are these compounds approved for human use?: No. Research-grade ipamorelin, CJC-1295, and sermorelin sold as reagents are not approved for human use. Titan supplies its blend strictly as a research-use-only compound for in-vitro laboratory work — not for human or animal consumption, and not for diagnostic, therapeutic, or preventative use.